Medical University of South Carolina Program

The Pediatric Hematology/Oncology Program at the Medical University of South Carolina specializes in providing comprehensive care for children with hematological and oncological conditions. The program is recognized for its dedication to improving life expectancy and quality of life for pediatric patients, ranging from initial treatment through adulthood. It boasts the only pediatric blood and marrow transplant (BMT) program and certified CAR-T immunotherapy program in the state, establishing itself as a leader in cutting-edge cancer treatments.

The program is consistently ranked among the top pediatric cancer programs nationally, demonstrating superior outcomes in blood and marrow transplants, with a notable report ranking it within the top 15 out of 193 programs in 2020. Such accolades highlight the program’s commitment to excellence in pediatric cancer care and outcomes 1.

Curriculum

The fellowship curriculum is designed to provide a robust educational experience with diverse clinical exposure. Penned under the guidance of experienced faculty members, the curriculum encompasses various aspects of pediatric hematology and oncology, including participation in multi-disciplinary clinics for brain tumors, hemophilia, and sickle cell disease.

The fellows are deeply involved in the daily operations of the clinics, contributing to patient care while also engaging in educational opportunities through lectures, seminars, and clinical trials. This approach ensures that fellows gain a thorough understanding of diseases, treatment modalities, and emerging therapies in the field.

Rotations

Fellows undertake a series of clinical rotations across the different subspecialties within pediatric hematology and oncology. Rotations include the Blood and Marrow Transplant Program, Brain Tumor Program, and the Hematology Clinic, each designed to provide extensive clinical exposure and hands-on experience with leading professionals.

For example, rotations in the Hemophilia Clinic allow fellows to collaborate with a multidisciplinary team to manage complex bleeding disorders while participating in national clinical trials 1. Additionally, they engage in a dedicated follow-up program for cancer survivors, known as the F.A.C.T. program, focusing on long-term side effects post-treatment.

Research Opportunities

Research is an integral component of the fellowship experience, with fellows gaining access to state-of-the-art facilities within the Darby Children’s Research Institute and the Hollings Cancer Center, both of which are at the forefront of pediatric cancer research. The program encourages fellows to actively participate in ongoing clinical trials and collaborates with various research consortiums 2.

Fellows may participate in clinical trials examining new therapies for conditions such as neuroblastoma and other solid tumors, providing a unique opportunity to contribute to advancing treatment protocols while gaining invaluable experience in clinical research methodologies.

Unique Aspects of the Program

The Pediatric Hematology/Oncology Program at MUSC stands out for its leading-edge treatment options, including participation in pioneering gene therapy trials for conditions like sickle cell disease. Fellows have the opportunity to engage in the evolving landscape of clinical trials and research 1.

Furthermore, the program fosters a collaborative environment among its faculty and trainees, emphasizing a team approach to patient care. Regular multi-disciplinary meetings and case discussions ensure fellows appreciate various perspectives in managing complex cases, thus bolstering their clinical decision-making skills.

Training Sites

The MUSC Children’s Hospital serves as the primary training site, equipped with cutting-edge facilities for patient treatment and research. The affiliation with the Hollings Cancer Center, South Carolina’s only NCI-designated cancer center, enhances the program’s research capabilities and outreach efforts, ensuring comprehensive training that addresses the health challenges faced by pediatric populations within the region 2.

Visa Sponsorship

The program supports various visa types for international medical graduates, facilitating opportunities for eligible fellows to train in its fellowship program. Specific information regarding visa sponsorship should be confirmed as it can vary depending on individual circumstances.

Competitiveness and Application Requirements

The Pediatric Hematology/Oncology fellowship at MUSC is competitive, seeking candidates with strong academic records and clinical experience in pediatric care. Specific application requirements may include details related to the year of graduation and performance on relevant medical licensing examinations, such as Step scores. It is advisable for prospective applicants to ensure they meet all set criteria before applying to strengthen their candidacy.